Bringing patients and providers together one tweet at a time

As an open forum for human interaction, social media have become the great equalizer of health information – providing a means for patients and health care providers to connect outside of the hospital or...

Know your third party patent rights

In the competitive world of the biosciences, third party patent rights (TPRs) can stand in the way of a planned course of action, even after significant investment has been made. Knowledge of such rights...

Making Pharmaceuticals person-specific

Dr Mohammed Maniruzzaman: Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex In this issue of BioScience Today, we speak to Dr Mohammed Maniruzzaman, Lecturer in Pharmaceutics and Drug Delivery at the University of Sussex,...

Patient capital is the key to unlocking growth in the life sciences sector

By Keith Morgan, CEO, British Business Bank The British Business Bank, as the UK’s national economic development bank, has a mission to make finance markets for smaller businesses operate more effectively, enabling those businesses to...

Surface research could help control infection

Another front in the war against infection is the introduction of antimicrobial surfaces into hospitals. By making the environment more hostile to pathogens such as Clostridium difficile and Staphilococcus aureus there will be less...

Concerns expressed on 
drug-resistant infections

Another major concern for those developing new drugs is the risk that illnesses become resistant to them, with significant worries about antibiotics. More than 80 leading international pharmaceutical, generics, diagnostics and biotechnology companies, as well...

Unlocking the secrets of a killer

Scientists are making significant progress to improve the testing and treatment of the killer illness salmonella. Achieving success is vital because every year almost one in ten people fall ill to food-borne illnesses, with many...

Facing a Changing Biosimilar Marketplace

Most people associate passage of the US Patient Protection and Affordable Care Act or ACA, (otherwise known as Obamacare) with extending health benefits to the under- and uninsured. But the legislation, signed into law in...

Everyday tablet could lead to relief for cancer sufferers

Another example of immunology at work is new research that suggests that giving cancer patients aspirin at the same time as immunotherapy could dramatically boost the effectiveness of the treatment. Francis Crick Institute researchers, funded...

Discovering a new future through Artificial Intelligence and Machine Learning

A number of industry sectors including aviation, retail and financial services have long applied data and utilised analytics to augment human capabilities, optimise their customer engagement and maximise returns. Indeed the term Artificial Intelligence (AI),...

Team edges closer to breakthrough

Finding a way to defeat drug-resistance is driving many research projects, including at the  University of East Anglia where scientists say they are getting closer to solving the problem of antibiotic resistance. New research has...

Reducing the risk of bio-contamination in gene, cell and CAR-T therapy

Bioquell’s Dr Rolf Hansen examines how the latest isolator systems create aseptic working conditions for reducing risk and keeping gene, cell and CAR-T therapies efficient, compliant and accurate, whilst also supporting biologics manufacturing expansion...

Nanomedicine – bridging the skills gap

Nanomedicine is at the forefront of modern healthcare. Nanoparticles offer a new platform for drug delivery that can extend the “patent life” of drugs, but also greatly increase the targeting and effectiveness of therapy. In...

The IP journey and risk mitigation

Paul Storer Senior Policy Adviser in the Business Support Policy Team at the IPO Resolving IP disputes can be costly and the Intellectual Property Office continues to seek to reduce costs for businesses, not only in...

Patients who have had an irregular heart beat can’t ever be considered ‘cured’, say...

Patients with an abnormal heart rhythm that can leave them at a higher risk of suffering from stroke still need treatment even after their heart rhythm seems to have returned to normal, say researchers...

Heart Disease: 
A primary cause of death

Dr Catrin Rutland BSc PGCHE MSc MMedSci PhD SFHEA FAS Heart disease is one of the primary causes of death throughout the world in both humans and animals. Research at The School of Veterinary Medicine...